NovoCure's Short-term Investments fell 1072.91% to $691.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $691.4 million, marking a year-over-year decrease of 1072.91%. This contributed to the annual value of $796.1 million for FY2024, which is 1885.82% up from last year.
NovoCure's Short-term Investments amounted to $691.4 million in Q3 2025, which was down 1072.91% from $761.9 million recorded in Q2 2025.
Over the past 5 years, NovoCure's Short-term Investments peaked at $854.1 million during Q4 2022, and registered a low of $243.9 million during Q3 2021.
For the 5-year period, NovoCure's Short-term Investments averaged around $684.0 million, with its median value being $741.6 million (2022).
In the last 5 years, NovoCure's Short-term Investments soared by 2641608.7% in 2021 and then tumbled by 4606.93% in 2024.
Over the past 5 years, NovoCure's Short-term Investments (Quarter) stood at $728.9 million in 2021, then rose by 17.18% to $854.1 million in 2022, then dropped by 21.58% to $669.8 million in 2023, then rose by 18.86% to $796.1 million in 2024, then dropped by 13.15% to $691.4 million in 2025.
Its Short-term Investments was $691.4 million in Q3 2025, compared to $761.9 million in Q2 2025 and $801.9 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value